Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy

Código QR

Prognostic implication of PD‐L1 polymorphisms in non‐small cell lung cancer treated with radiotherapy

Abstract Background To investigate the impact of programmed death‐ligand 1 (PD‐L1) polymorphisms on the prognosis of non‐small cell lung cancer (NSCLC) patients treated with curative radiotherapy. Methods Four single nucleotide polymorphisms (SNPs) (rs822336G>C, rs822337T>A, rs822338C>T, an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Min Kyu Kang, Shin Yup Lee, Jin Eun Choi, Sook Kyung Do, Moon‐June Cho, Jun‐Sang Kim, Jae Yong Park
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	non‐small cell lung cancer PD‐L1 polymorphisms radiotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/9fb4f3f87b164d22987a18702f7ec04d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Safety of thoracic radiotherapy after PD‐(L)1 inhibitor treatment in patients with lung cancer
por: Yu Chen, et al.
Publicado: (2021)

Plasmatic Levels of HSP90α at Diagnosis: A Novel Prognostic Indicator of Clinical Outcome in Advanced Lung Cancer Patients Treated With PD-1/PD-L1 Inhibitors Plus Chemotherapy
por: Shubin Chen, et al.
Publicado: (2021)

Hemoglobin A1c level is a prognostic factor for locoregional recurrence in stage III non‐small cell lung cancer patients treated with radiotherapy
por: Moonkyoo Kong, et al.
Publicado: (2021)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shijie Shang, et al.
Publicado: (2021)

Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
por: Yanhao Liu, et al.
Publicado: (2021)

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
por: He Ba, et al.
Publicado: (2021)

Clinical Research Progress of Radiotherapy Combined with Immune Checkpoint Inhibitors on NSCLC
por: ZHU Kuikui, et al.
Publicado: (2021)

Dl-3-N-Butylphthalide Presents Anti-Cancer Activity in Lung Cancer by Targeting PD-1/PD-L1 Signaling
por: Jiang Q, et al.
Publicado: (2021)

Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database
por: Deng Chen, et al.
Publicado: (2021)

Efficacy of PD‐1/PD‐L1 inhibitors in patients with non‐small cell lung cancer and brain metastases: A real‐world retrospective study in China
por: Jiamin Sheng, et al.
Publicado: (2021)

Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer
por: Ning-Yi Ma, et al.
Publicado: (2021)

Research Progress in CircRNA and Radiotherapy Resistance of Non-small Cell Lung Cancer
por: Weilong LI, et al.
Publicado: (2021)

Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapy
por: Jin Meng, et al.
Publicado: (2021)

Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization
por: Mohammad U. Zahid, et al.
Publicado: (2021)

Comparison of Clinical Outcomes of Definitive and Postoperative Radiotherapy for Adenoid Cystic Carcinoma of the Head and Neck: Can Definitive Radiotherapy Be a Treatment Option?
por: Nobutaka Mizoguchi, et al.
Publicado: (2021)

Impact of Preoperative vs Postoperative Radiotherapy on Overall Survival of Locally Advanced Breast Cancer Patients
por: Yujiao Deng, et al.
Publicado: (2021)

How to Exert Role of Radiotherapy in Treatment of Pancreatic Cancer
por: REN Gang, et al.
Publicado: (2021)

Application of Radiosensitizers in Cancer Radiotherapy
por: Gong L, et al.
Publicado: (2021)

Treatment-Related Adverse Events with PD-1 or PD-L1 Inhibitors: A Systematic Review and Meta-Analysis
por: Yixi Zhang, et al.
Publicado: (2021)

Various Uses of PD1/PD-L1 Inhibitor in Oncology: Opportunities and Challenges
por: Zhitao Li, et al.
Publicado: (2021)

Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study
por: Marie-Christina Jahreiß, et al.
Publicado: (2021)

Anti-PD-1 Immunotherapy Combined With Stereotactic Body Radiation Therapy and GM-CSF as Salvage Therapy in a PD-L1-Positive Patient With Refractory Metastatic Thyroid Hürthle Cell Carcinoma: A Case Report and Literature Review
por: Haihua He, et al.
Publicado: (2021)

Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis
por: Jianguo Han, et al.
Publicado: (2021)

Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
por: Guangchuan Deng, et al.
Publicado: (2021)

Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies
por: Eleni Gkika, et al.
Publicado: (2021)

Stomach cancer. Clinical significance of the expression of key components of PD-1/PD-L1 immune checkpoint
por: Olga V. Kovaleva, et al.
Publicado: (2021)

Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
por: Denis I. Yudin, et al.
Publicado: (2021)

A retrospective study of clinicopathologic and molecular features of inoperable early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy
por: I-Han Lee, et al.
Publicado: (2021)

Practical Guidelines on Implementing Hypofractionated Radiotherapy for Prostate Cancer in Africa
por: William Swanson, et al.
Publicado: (2021)

Associations Between CAMKK1 Polymorphism rs7214723 and the Prognosis of Patients With Lung Cancer
por: Haorui Zhang, et al.
Publicado: (2021)

The Radiotherapy Role in the Multidisciplinary Management of Locally Advanced Vulvar Cancer: A Multidisciplinary VulCan Team Review
por: Luca Tagliaferri, et al.
Publicado: (2021)

Novel prognostic classification predicts overall survival of patients receiving salvage whole-brain radiotherapy for recurrent brain metastasis from breast cancer: A recursive partitioning analysis (KROG 16-12)
por: Jae Sik Kim, et al.
Publicado: (2021)

Results of Radiation Therapy as Local Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer
por: David L. Billing, et al.
Publicado: (2021)

Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival
por: Peiyi Xie, et al.
Publicado: (2021)

lnterleukin-8 gene polymorphism and susceptibility to gastric cancer in a brazilian population
por: Felipe,Aledson V, et al.
Publicado: (2012)

Radiotherapy in the Treatment of Subcutaneous Melanoma
por: Valentina Borzillo, et al.
Publicado: (2021)

Application of PD-L1, PD-L2, CD30, CD23 and BCL-6 in Diagnosis and Prognostic Evaluation of Primary Mediastinal Large B-cell Lymphoma
por: YUAN Ting, et al.
Publicado: (2021)

The Potential Advantage of Targeting Both PD-L1/PD-L2/PD-1 and IL-10–IL-10R Pathways in Acute Myeloid Leukemia
por: Laura Jimbu, et al.
Publicado: (2021)

MR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands
por: Janita E. van Timmeren, et al.
Publicado: (2021)

Radiotherapy Treatment for Melanoma Skin Cancer Disease
por: Wahyu Irawati, et al.
Publicado: (2021)